Načítá se...
Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab – a case report
Much excitement has been generated with the approval of idarucizumab, a humanized monoclonal antigen‐binding antibody fragment that is capable of reversing the anticoagulant activity of dabigatran. Here, we describe our initial experience of using tissue plasminogen activator (tPA) in an acute poste...
Uloženo v:
| Vydáno v: | Ann Clin Transl Neurol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5099535/ https://ncbi.nlm.nih.gov/pubmed/27844035 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.346 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|